Amelioration of Morphine Withdrawal Syndrome by Systemic and Intranasal Administration of Mesenchymal Stem Cell-Derived Secretome in Preclinical Models of Morphine Dependence

Administration of secretome derived from hMSCs reduces the development of opioid withdrawal signs, which correlated with a reduction in neuroinflammation in the hippocampus and nucleus accumbens.